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Abstract
Background: Self-administered questionnaires are becoming increasingly common in general
practice. Much research has explored methods to increase response rates but comparatively few
studies have explored the effect of questionnaire administration on reported answers.
Methods: The aim of this study was to determine the effect on responses of returning patient
questionnaires to the respondents' medical practice or an independent researcher to questions
relating to adherence and satisfaction with a GP consultation. One medical practice in Waveney
primary care trust, Suffolk, England participated in this randomised trial. Patients over 18 years
initiated on a new long-term medication during a consultation with a GP were randomly allocated
to return a survey from their medical practice to either their medical practice or an independent
researcher. The main outcome measures were self reported adherence, satisfaction with
information about the newly prescribed medicine, the consultation and involvement in discussions.
Results:  274 (47%) patients responded to the questionnaire (45% medical practice, 48%
independent researcher (95% CI -5 to 11%, p = 0.46)) and the groups appeared demographically
comparable, although the high level of non-response limits the ability to assess this. There were no
significant differences between the groups with respect to total adherence or any of the satisfaction
scales. Five (4%) patients reported altering doses of medication in the medical practice group
compared with 18 (13%) in the researcher group (P = 0.009, Fisher's exact test). More patients in
the medical practice group reported difficulties using their medication compared to the researcher
group (46 (35%) v 30 (21%); p = 0.015, Fisher's exact test).
Conclusion: Postal satisfaction questionnaires do not appear to be affected by whether they are
returned to the patient's own medical practice or an independent researcher. However, returning
postal questionnaires relating to detailed patient behaviours may be subject to response biases and
further work is needed to explore this phenomena.
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Background
Patient surveys are becoming an increasingly common
tool to measure quality and improve services [1].
Although doubts remain over the validity of these surveys
in assessing quality of care [2,3] the current General Med-
ical Services (GMS) contract provides additional financial
remuneration for conducting patient surveys. Further-
more, it is proposed that in the future these surveys will
require patients to provide even greater detail about their
consultations [4].
While much research has investigated the administration
of patient surveys, the majority has explored methods to
increase response rates [5]. Intense survey methods have
been reported to yield greater response rates [6], however
postal questionnaires appear to remain the most cost
effective mode of administration [7,8]. It has also been
suggested that responses to postal questionnaires are
likely to be more accurate than other methods when
enquiring about sensitive issues such as health and behav-
iour [9-11].
It is unsurprising therefore that self-administered postal
questionnaires have been widely adopted as the survey
method of choice. However, it is not known how subtle
differences within this method of administration affects
elicited responses [8,10]. Results from a small medical
practice audit of patient self reported adherence suggested
no patients deviated from the instruction given to them by
their doctor when the self administered questionnaire was
returned to the patients own medical practice. This is in
sharp contrast to literature where self reported adherence
to medication for chronic conditions is usually 50%, and
therefore led us to the hypothesis that patients returning
questionnaires regarding potentially "deviant" behaviour
(in this case non-adherence to medication) directly to
their medical practice might be unwilling to report this.
Questions on adherence may be subject to additional
response biases if administered by the patient's own med-
ical practice. Fear of reprisals and the reluctance to express
aversion to medicines may increase bias of previously val-
idated questionnaires despite assurances of confidential-
ity [12-14]. In addition, questionnaires which include
questions regarding satisfaction with the doctors consul-
tation and the information provided may also demon-
strate socially desirable responses with higher levels of
reported satisfaction if returned directly back to the med-
ical practice of the patient. Although a number of
researchers have required patients to submit responses to
independent researchers [15,16], greater understanding of
this administrative method is needed.
We therefore performed a randomised controlled trial
with the primary aim of determining whether patients
returning questionnaires relating to their GP consultation
to either their medical practice or an independent
researcher affects patients' reports of their adherence. The
secondary aims of this research to explore the compo-
nents of GP consultations which affect medication adher-
ence will be reported later.
Methods
Sample
The study was conducted in one medical practice in Suf-
folk and approved by the Norfolk research ethics commit-
tee prior to commencement of data collection. During the
study period, the practice had a list size of 10,000 patients,
with 10 GPs conducting consultations. Patients over 18
years, who had been initiated on to a long-term medica-
tion by the GP in a consultation at the practice, were
invited to participate. The sample only included patients
prescribed one de novo solid oral dosage form (or
inhaler) medication with a specified daily dosage (exclud-
ing PRN medication) and did not included courses of
medicines prescribed for the treatment of acute condi-
tions. Patients were randomised to return their question-
naire to either the medical practice or an independent
researcher by the opening of randomly allocated opaque
envelopes in chronological order, blocked in varying
lengths and stratified by GP.
Procedures
The study was performed between November 2005 and
August 2006, as a randomised control trial. Potential par-
ticipants were not aware of the randomisation and were
only told the research was interested in their recent visit to
the doctor. Those allocated to the medical practice group
were sent a questionnaire with an introductory paragraph
from the medical practice and a pre-paid reply envelope
addressed to the medical practice. Those allocated to the
researcher group were sent a questionnaire with an intro-
ductory paragraph from the researcher and a pre-paid
reply envelope addressed to the researcher (see additional
files 1 and 2). The questionnaires were otherwise identical
and sent to patients with the consent form seven days after
the index consultation. The allocation was performed by
a receptionist and both GPs and patients were blinded to
the allocation. Non-responders were sent a second post-
ing of the questionnaire after two weeks.
Measurements
The questionnaire was developed from existing tools
available from the medicine partnership [17] designed to
explore components important for achieving concord-
ance. The Medication Adherence Report Scale
(MARS)[18] was used to measure adherence to the newly
prescribed medication. This scale requires patients to
report their frequency of behaviour relating to five non-
adherence behaviours; forgetting, missing, altering, takingBMC Medical Research Methodology 2008, 8:42 http://www.biomedcentral.com/1471-2288/8/42
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less and stopping medication where 5 = never, 4 = rarely,
3 = sometimes, 2 = often and 1 = always. The Satisfaction
with Information about Medicines Scale (SIMS)[19] is a
validated questionnaire providing a profile of patients'
satisfaction with the information they have received about
their newly initiated medication. It consists of 17 items
requesting patients to rate the amount of information
received on each item as: 'too much', 'about right', 'too lit-
tle', 'none received' and 'none needed'. The Perception of
Involvement in Discussions (PID) [20] requires patients
to rate how much they agree with four statements relating
to their involvement in discussions on a 5-point Likert
scale ranging from 'strongly agree' to 'strongly disagree'.
The Medication Interview Satisfaction Scale (MISS-
21)[21] asks patients to rate 21 statements about their sat-
isfaction with their consultation on a 7-point Likert scale
ranging from 'very strongly disagree' to 'very strongly
agree'. The questionnaire additionally included a checklist
of potential difficulties patients may have with using their
medication, e.g. opening lids or swallowing tablets.
Patient characteristics were extracted from practice medi-
cal records by a researcher on patient completion of the
questionnaire. These included: gender, age, living status,
number of prescribed daily medications, number of pre-
scribed 'when required' medication, current active prob-
lems and details of the newly prescribed medications.
Sample size calculation
Initial responses to a practice audit of adherence (a survey
returned directly to the medical practice) demonstrated
100% of patients scoring 25 (perfect score) using the
MARS questionnaire. A previous study using the MARS
questionnaire returned to a researcher, reported 80% of
patients scoring 25 [22]. Therefore it was calculated that
274 patients (137 in each group) would be required to
detect a conservative 95 versus 85% difference in patients
scoring 25 using the MARS questionnaire with 80% power
and using a 5% significance level. There was a paucity of
data on the likely response rates to inform calculations of
how many patients would need to be sent questionnaires
to yield an achieved sample size of 274. In the absence of
such data, identification and recruitment of study partici-
pants continued until 274 completed questionnaires had
been received.
Data analysis
Responders and non responders were compared with
respect to age and gender. The medical practice and
researcher groups were compared according to patient
characteristics and the newly prescribed medicine. MARS
scores were dichotomised into either 'adherent' (score =
25) or 'partially adherent' (score < 25). This was further
subdivided by dichotomising each of the non-adherent
behaviours as not occurring (score = 5) or occurring (score
< 5). The proportion of patients in each group who
reported adherence was compared using the Fisher's exact
test with confidence intervals calculated assuming the
normal approximation to the binomial. The SIMS, MISS-
21 total scores and subscale scores and response to each
individual "Perception of involvement in discussions"
questions were compared between groups using the Mann
Whitney U test as distributions were expected to be
skewed. The proportion of patients reporting difficulties
with medication in each group was compared using the
Fisher's exact test. Data manipulation was carried out
using SPSS version 14 with statistical significance set at
5%.
Results
Invitations to participate were extended to 585 patients;
274 (46.8%) patients agreed and completed the question-
naire (figure 1). There was no difference in the recruit-
ment of patients between each randomisation group
(45% medical practice vs. 48% researcher, (95% CI -5 to
11%) p = 0.508), however non-responders were younger
than responders (mean age = 59.2 v 63.4 years, p = 0.011)
but response was not related to gender. The remainder of
this paper focuses on the responders and table 1 shows
both groups were very similar at baseline. However, with
less than a 50% response rate, the study groups may not
be comparable with respect to any unobserved variables.
Adherence
The overall proportion of patients reporting being adher-
ent was markedly lower than expected from the previously
reported rate of 100% in the medical practice audit or
80% reported by Bhattacharya [22]. There was no signifi-
cant difference in the proportion of patients who reported
being adherent between the medical practice and
researcher groups (40.9% v 45.1%, p = 0.54 difference in
proportions 95% CI -14.7% to 23.1%). Figure 2 shows the
exploratory secondary analysis of the types of non-adher-
ent behaviour. This figure reveals that a smaller propor-
tion of patients reported altering doses in the medical
practice group (3.8% v 12.7%, p = 0.009, difference in
proportions 95% CI 2.5% to 15.3%). There were no dif-
ferences reported in the frequency of the other types of
non-adherent behaviour or the proportion of missing sur-
vey items between the groups.
Satisfaction
Table 2 shows the total and subscale scores for the SIMS
and MISS-21 survey sections. There was no difference in
responses between groups; however, only 32.5% of the
medical practice group and 29.1% of the researcher group
were completely satisfied with the amount of information
they had received about their newly prescribed medicine.
In response to individual questions in this section of the
questionnaire, only eight patients reported receiving too
much information from their GP. MISS-21 scores wereBMC Medical Research Methodology 2008, 8:42 http://www.biomedcentral.com/1471-2288/8/42
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similar; 35.6% and 31.0% of patients reporting satisfac-
tion with all items respectively.
Involvement in discussions
There were no significant differences between the groups
in reporting involvement in discussion about treatment
(table 3). In both groups, approximately half the respond-
ents agreed that they received enough information and
were given responsibility for deciding how to deal with
their health problem. Yet only 13% of respondents
reported being asked to choose a treatment for their
health problem.
Difficulties using medication
Patients in the medical practice group were significantly
more likely to report difficulties using their medication
(34.8% medical practice v 21.1% researcher, p = 0.015).
The most frequently reported difficulties were opening
lids and remembering times of day and days of the week
(Table 4).
Table 1: Baseline comparison of medical practice and researcher group patients. Values are numbers (percentages) unless stated 
otherwise.
Characteristic Medical Practice (n = 132) Researcher (n = 142)
Female 82 (62.1) 88 (62.0)
Median (Q1–Q3) Age (years) 62.0 (51.3–74.8) 65.0 (54.0–74.0)
Living alone 23 (17.4) 25 (17.6)
Median (Q1–Q3) Daily drugs 3.0 (2.0–5.8) 3.0 (2.0–5.0)
Median (Q1–Q3) PRN drugs 1.0 (0.0–1.0) 1.0 (0.0–2.0)
Active problems
Diseases of circulatory system 89 (67.4) 92 (64.8)
Hypertension 51 (38.6) 55 (38.7)
Ischemic Heart Disease 18 (13.6) 13 (9.2)
Cerebrovascular Disease 13 (9.8) 12 (8.5)
Other forms of heart disease 7 (5.3) 12 (8.5)
Asthma/COPD 29 (21.9) 35 (24.6)
Diabetes Mellitus 23 (17.4) 23 (16.2)
Disorders of the thyroid gland 14 (10.6) 12 (8.5)
Mood [affective] disorders 16 (12.1) 21 (14.8)
Eye & adnexa 12 (9.1) 14 (9.9)
Digestive system 25 (18.9) 29 (20.4)
Skin & subcutaneous tissue 11 (8.3) 10 (7.0)
Musculatory system & connective tissue 34 (25.8) 44 (30.9)
Genitourinary 24 (18.2) 23 (16.2)
Other 34 (25.8) 23 (16.2)
Newly prescribed medication
Cardiovascular system 66 (50.0) 70 (49.3)
Diuretics 3 (2.3) 12 (8.5)
Beta-blockers 5 (3.8) 9 (6.3)
ACE inhibitors or ARAs 21 (15.9) 12 (8.5)
Calcium-channel blockers 3 (2.3) 14 (9.9)
Lipid regulating drugs 19 (14.4) 12 (8.5)
Respiratory system 14 (10.6) 10 (7.0)
Central nervous system 12 (9.1) 12 (8.5)
Endocrine system 18 (13.6) 21 (14.8)
Obstetrics & gynaecology 13 (9.8) 14 (9.9)
Others 9 (6.8) 15 (10.6)
Dosage form
Tablets or Capsules 114 (86.4) 132 (93.0)
Inhalers 13 (9.8) 8 (5.6)
Others 5 (3.8) 2 (1.4)
Dosage frequency
Less than daily 4 (3.0) 6 (4.2)
Daily 103 (78.0) 118 (83.1)
More than daily 24 (18.2) 17 (12.0)
Unknown 1 (0.8) 1 (0.7)
(Q1–Q3) = lower quartile – upper quartile
ACE = Angiotensin-converting enzyme inhibitors
ARAs = Angiotensin-II receptor antagonistsBMC Medical Research Methodology 2008, 8:42 http://www.biomedcentral.com/1471-2288/8/42
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Discussion
This is the first randomised controlled study to investigate
whether patients give different responses to question-
naires regarding detailed aspects of their consultation
including medication adherence which they return to
their own medical practice, in comparison to those
returned to an independent researcher. The survey was
conducted from one medical practice in Suffolk.
Summary of main findings
The study found no significant differences in the propor-
tion of patients reporting being adherent or in the satisfac-
tion levels of components of the consultation between
The proportion of patients reporting the different types of non-adherent behaviours of the medication adherence report scale Figure 2
The proportion of patients reporting the different types of non-adherent behaviours of the medication adherence report scale.
0 1 02 03 04 05
Take less than instructed
Miss out a dose
Stop taking for a while
Alter the dose
Forget to take them
Proportion of patients (%)
06 0
Medical Practice Researcher
Flowchart showing progress of patients through trial Figure 1
Flowchart showing progress of patients through trial.
Assessed for eligibility and 
randomised (n=585) 
Medical Practice (n=291) 
Refused to participate (n=97) 
Researcher (n=294) 
Refused to participate (n=99)  Allocation
No response (n=62)  No response (n=53) 
Analysed (n=132) 45.4%  Analysed (n=142) 48.3%  Analysis BMC Medical Research Methodology 2008, 8:42 http://www.biomedcentral.com/1471-2288/8/42
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submitting responses to the medical practice or an inde-
pendent researcher. Significant differences did exist in the
secondary outcomes of reporting reasons for non-adher-
ence and difficulties using medication. Fewer patients
reported altering doses of medication and more patients
reported difficulties using their medication in the medical
practice group.
Comparison with existing literature
Consistent with previous data [23,24], we found approxi-
mately 50% of patients reported non-adherence when
classifying patients as non-adherent if they scored < 25 on
MARS. However, the mean MARS scores were higher than
previously reported [25] suggesting patients were either:
only reporting one type of non-adherent behaviour, or
more likely, patients had restricted opportunity to deviate
because of the limited time between initial prescribing
and survey completion. MARS and other self reported
adherence measures tend to overestimate adherence, but
are highly accurate for patients who report non-adherence
(minimal false positives) [26,27]. This study may have
also over estimated the absolute level of non-adherence.
With a response rate of less than 50% only those more
adherent participants may have responded, although we
believe that this effect would be consistent in both groups.
All satisfaction scale scores were similar to previous stud-
ies [20,21,26].
Comparisons of self administered questionnaire tech-
niques (email, postal, handing out questionnaires to
patients) appear to find no differences in responses for
health satisfaction surveys [28,29] and this study suggests
administration differences within the postal technique
will also not affect reported satisfaction. Despite equal
Table 3: Perception of involvement in discussions. Values are numbers (percentages) unless otherwise stated.
Medical Practice (N = 132) Researcher (N = 142)
Agree with item Completed* Agree with item Completed*
The doctor gave me responsibility for deciding how to deal with my health 
problems
60 (45.5) 124 (93.9) 50 (35.2) 134 (94.4)
The doctor asked me to choose a treatment for my health problem 18 (13.6) 122 (92.4) 18 (12.7) 132 (93.0)
The doctor gave me enough information to make my own decision about 
treatment
65 (49.2) 127 (96.2) 69 (48.6) 137 (96.5)
The doctor did not ask my opinion about my medicines 34 (25.8) 123 (93.2) 42 (29.6) 135 (95.1)
*Patients who completed the item
Table 2: Satisfaction scales scores
Satisfaction Scale Possible Score 
Range
Medical Practice (N = 132) Researcher (N = 142)
Score Mean 
(SD)
Satisfied* N (%) Completed 
items** N (%)
Score Mean 
(SD)
Satisfied* N (%) Completed 
items** N (%)
SIMS
Action and 
usage
0–9 7.5 (1.8) 54 (40.9) 119 (90.2) 7.5 (1.9) 60 (42.3) 132 (92.9)
Potential 
problems of 
medication
0–8 6.2 (2.1) 50 (37.9) 117 (88.6) 6.3 (2.1) 55 (38.7) 130 (91.5)
Overall 
satisfaction
0–17 13.8 (3.4) 37 (28.0) 114 (86.4) 13.8 (3.6) 37 (26.1) 127 (89.4)
MISS-21
Distress relief 6–42 30.7 (4.9) 63 (47.7) 121 (91.7) 30.5 (5.0) 56 (39.4) 131 (92.3)
Communic-
ation comfort
4–28 21.4 (3.7) 86 (65.2) 123 (93.2) 21.6 (4.1) 88 (62.0) 132 (93.0)
Rapport 8–56 45.0 (7.4) 92 (69.7) 124 (93.9) 44.8 (6.4) 104 (73.2) 135 (95.1)
Compliance 
intent
3–21 16.0 (3.0) 93 (70.5) 126 (95.5) 16.4 (2.9) 108 (76.1) 137 (96.5)
Overall 
satisfaction
21–147 112.8 (15.4) 47 (35.6) 113 (85.6) 113.2 (15.1) 44 (31.0) 124 (87.3)
*Participants who marked 'about right' or 'none needed' on SIMS scale items or who scored ≥ 5 on MISS-21 scale items
**Participants who completed all items in the scaleBMC Medical Research Methodology 2008, 8:42 http://www.biomedcentral.com/1471-2288/8/42
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assurances of confidentiality, we believe the differences
observed between the two groups in terms of reporting
adherence and difficulties using medication may be a
result of patients not wanting to appear responsible for
their non-adherence. Though it is possible that these sec-
ondary outcomes are non significant and should only be
considered as exploratory. Earlier studies have described
how patients find it difficult to express an aversion to
medicines directly to their GP [12,13], thus reporting for-
getting rather than altering doses may be more socially
desirable for surveys returned directly to the patient's
medical practice. The increase in reported problems using
medicines in the medical practice group also corresponds
to socially desirable responses, as patients attempt to jus-
tify their non-adherence as unintentional and not a con-
scious deviation from instructions.
There was no difference in response rate to the overall
questionnaire or individual items on the questionnaire,
which contrasts previous research comparing response
rates between similar groups [30]. Smith et al.'s study used
a general health survey on heart disease to compare
response rates between questionnaires introduced and
returned to the patients' general practitioner and those
introduced and returned to a doctor at a research unit. The
overall response rate in the general practitioner group was
85% compared to 75% in the research unit arm. There are
a number of possible explanations why this study received
a higher response rate overall and a difference in response
between the two groups not observed in our study. Smith
et al.'s study occurred more than 20 years ago and since
this time there has been a general decline in response rates
to questionnaires. Furthermore it only targeted patients
aged between 40 and 59 years with non response higher
in younger age groups [31]. The content of the question-
naire (a general health survey) may explain the difference
in response between the two groups, as the perceived
importance of the questionnaire in the medical practice
arm may have been increased, an effect not demonstrated
in our questionnaire regarding a specific consultation.
Strengths and limitations of this study
The results of this study should be viewed in the context
of several limitations. This study occurred in one medical
practice with a practice size of 10,000; although all 10 GPs
were involved, it may not be generalisable to other prac-
tices, especially very small single handed practices where
patients consult the same GP. The results therefore should
be replicated in a wider variety of settings. However, the
poor response rate (47%) makes it impossible to be sure
whether randomisation ensured comparability between
the groups at baseline, though for the recorded baseline
variables the two groups were comparable. The response
rate and age difference of non-responders was consistent
with other similar postal questionnaires [32,33]. However
it may be necessary to explore other more intensive modes
of administration to see if responses to questions request-
ing similar information are significantly different. Twenty
statistical tests were performed on secondary outcomes in
this study, as it was not powered for these analyses one
false positive result would be expected and we made no
correction for multiple testing. Therefore our significant
findings should be considered exploratory. The patients'
ability to identify the survey recipient may have been
decreased by ethical requirements to enclose a covering
letter from the medical practice. This letter was on practice
headed paper and asked patients to read the enclosed
information regarding a research project. To determine
the true extent of response differences the ideal research
design would have been a factorial design involving four
cells (sent by practice returned to practice; sent by practice
returned to independent researcher; sent by independent
researcher returned to practice; sent by independent
researcher returned to independent researcher). However,
Table 4: Potential difficulties using medication. Values are numbers (percentages) unless stated otherwise
Difficulty Medical Practice (n = 132) Researcher (n = 142)
Opening lids 16 (12.1) 12 (8.5)
Using blister packs 9 (6.8) 9 (6.3)
Understanding directions 3 (2.3) 2 (1.4)
Swallowing tablets 8 (6.1) 5 (3.5)
Splitting tablets 3 (2.3) 4 (2.8)
Pouring liquids 1 (0.8) 2 (1.4)
Reading labels 0 (0.0) 4 (2.8)
Managing eye/ear drops 6 (4.5) 4 (2.8)
Picking up tablets 6 (4.5) 5 (3.5)
Using other devices 1 (0.8) 1 (0.7)
Remembering days/times 12 (9.1) 4 (2.8)
Overall
Any difficulties reported1 46 (34.8)* 30 (21.1)*
1 Patients who reported one or more difficulties using their medication. *p < 0.05 Fisher's exactBMC Medical Research Methodology 2008, 8:42 http://www.biomedcentral.com/1471-2288/8/42
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this design is not possible with current ethical and data
protection concerns, hence the pragmatic nature of our
design. Additional qualitative analysis would have helped
to determine the significance of the covering letter and
explore reasons for specific responses. As a randomised
controlled trial it was hoped that this study would be able
to detect genuine differences in responses between
respondents that were not a result of different settings
which is a general limitation of much of the literature on
modes of questionnaire administration [10]. However,
the level of non-response makes it impossible to assess if
the groups were comparable at baseline.
Conclusion
This study found no difference in recorded adherence or
satisfaction between our two groups. Assuming the groups
were comparable at baseline it therefore supports the
validity of returning existing patient satisfaction question-
naires used in the current GMS contract to the patients'
medical practice. Our secondary findings led us to the
hypothesis that if questionnaires are extended to explore
more detailed experiences of consultations and patient
behaviours, responses may be subject to additional
response bias. In our case we believe social desirability
bias to be responsible for the differences observed and any
method able to reduce this phenomena with behavioural
questions is of benefit to future questionnaires [34].
In the future research should compare questionnaire
response to measurable outcomes where possible to help
determine the accuracy of responses. While maximising
response rates remains important, greater consideration
should be placed on the quality of responses for question-
naires which explore patient behaviours. Every aspect of
survey administration should be carefully considered as it
may confer important affects on responses.
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